MedTrace Logo

Concentration of Ampicillin / Sulbactam and Amoxicillin / Clavulanic Acid in the Blood During Renal Replacement Therapy in Longterm Renal Replacement Therapy Patients

NCT02007603 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2017-05-31

No results posted yet for this study

Summary

The study will be conducted to investigate the pharmacokinetics of ampicillin / sulbactam and amoxicillin/clavulanic acid during intermittent haemodialysis.

Conditions

  • Infection During Hemodialysis

Interventions

DRUG

Administration of Amoxicillin / clavulanic acid

Patients receive amoxicillin / clavulanic acid due to clinical necessity

DRUG

Ampicillin / sulbactam

Patients receive ampicillin / sulbactam due to clinical necessity

PROCEDURE

Blooddraws for pharmacokinetic profiling

Blood will be sampled at multiple timepoints during multiple hemodialysis sessions

Sponsors & Collaborators

  • Medical University of Vienna

    lead OTHER

Principal Investigators

  • Florian Thalhammer, Prof. MD · Medical University of Vienna

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2015-02-28
Completion
2017-05-31

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02007603 on ClinicalTrials.gov